Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sedative effect of midazolam syrup 0.3 vs 0.5 mg/kg in pediatric dentistry
IRCT201406171882N6Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of midazolam in anxiety disorder and Procedural anxiety (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Sedation effectiveness. Started Jul 2013; status: completed.
02
Drugs
midazolam
03
Conditions
anxiety disorderProcedural anxiety
Beyond the preview
Go deeper on IRCT201406171882N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201406171882N6.